Denampo, Felipe A.
HRN: 23-70-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/11/2023
09/18/2023
IV
1.5g
28
Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes